|
Market Closed -
Sao Paulo
20:45:54 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 136.35 BRL | -4.23% |
|
-5.40% | -19.16% |
| 10-02 | AbbVie joins US government pilot to test drug discount rebates | RE |
| 10-02 | Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
AstraZeneca PLC(AZN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
AstraZeneca PLC(AZN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
AstraZeneca PLC(AZN)
EBIT
Dividend / Share (DPS)
Data source:
AstraZeneca PLC(AZN)
Cash or Net Debt
- Stock Market
- Stocks
- AZN Stock
- A1ZN34 Stock
- Consensus AstraZeneca PLC
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
